Astellas Pharma Inc.

Astellas Pharma Inc. Stock

12.80P/E
€28.39BMarket capitalisation
JP¥214.58Earnings
2.78 %Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Astellas Pharma Inc is a specialty international pharmaceutical company. The company focuses on accelerating the discovery, development, and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases. The group is committed to driving innovation in immuno-oncology, gene therapy, mitochondria, blindness and regeneration, and targeted protein degradation. Its core products include anticancer agents like XTANDI, XOSPATA, and PADCEV; VEOZAH for the treatment of vasomotor symptoms due to menopause; Betanis / Myrbetriq / BETMIGA for the treatment of overactive bladder (OAB); and Prograf, an immunosuppressant for organ transplantation.

Astellas Pharma Inc. is registered in the following country: Japan (Exchange: JPTSE).

Key metrics

Key metrics and master data for the Astellas Pharma Inc. stock.

Market capitalisation
€28.39B
P/E
12.80
P/B
2.41
P/S
2.07
P/CF
8.70
Issued shares 2B Units

Return

Here you can see the performance of the Astellas Pharma Inc. stock.

PeriodPerfor­mance
1 Week+1.33 %
1 Month+12.59 %
3 Months+23.58 %
6 Months+23.58 %
1 Year+46.72 %
YTD+36.57 %

Dividends

The Astellas Pharma Inc. stock pays an annual dividend. With an (expected) annual dividend of £0.43, the current stock price results in a dividend yield of 2.78 %.

Dividend typeAnnual dividend
(Expected) annual dividend £0.43
Dividend yield 2.78 %

Splits

The table shows the splits of the Astellas Pharma Inc. share.

DateRatio
27.03.20145:1

Which ETF contains the Astellas Pharma Inc. stock?

The Astellas Pharma Inc. stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Astellas Pharma Inc. has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Astellas Pharma Inc. stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.